February 25, 2025 12:31 PM ESTUpdated 01:20 PM
Financing
Startups
China

En vogue Chi­nese ADC biotech lets Hong Kong IPO fil­ing lapse

Kyle LaHucik

Senior Reporter

Du­al­i­ty Bi­o­log­ics, an ADC start­up that’s at­tract­ed mul­ti­ple bio­phar­ma part­ner­ships, has let its plans to list on the Hong Kong Stock Ex­change …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lil­ly pays $10M up­front for Organo­vo’s FXR ag­o­nist pro­gram

Where the mon­ey is: The top 100 ven­ture in­vestors in biotech

Re­pare to lay off 75% of staff; Cas­tle Creek inks $75M roy­al­ty deal

Al­ny­lam eyes big­ger dis­eases in more tis­sue types at ‘in­flec­tion point’ for siR­NA

Hims eyes growth in its weight loss busi­ness, de­spite end of semaglu­tide short­age

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times